Roy Lipski's guest appearances

Roy Lipski

The Thoughtful Entrepreneur

Kannaboom | CBD and Cannabis for Wellness

The Purpose-Driven Entrepreneur

Michael Ayalon

Jon Ostenson

Mike Sowers

Marques Ogden

Maya Gaddie

Chris Dreyer

Michelle Seiler Tucker

Olin Hyde

Mary Grothe

Belinda Ellsworth

Jonathan Troen

Tom Jackobs

Bart Rupert

Jeremy Parker

Adam Clark

OwlTail

https://www.linkedin.com/in/roylipski/ https://creoingredients.com/

<a href="https://www.linkedin.com/in/roylipski/" rel="nofollow" target="_blank">https://www.linkedin.com/in/roylipski/</a> <a href="https://creoingredients.com/" rel="nofollow" target="_blank">https://creoingredients.com/</a>

73. Roy Lipski, CEO and Co-founder of Creo

Biosynthetic compounds — including cannabinoids — present the 'last great domestication' says Roy Lipski, CEO of Creo. His company is at the forefront of bringing lab-produced cannabinoids to market, at scale.  Cosmetics and creams will be among the first products to take advantage of this technology and we can look for these products on store shelves in the not-too-distant future. Tune in to hear how:Microorganisms can produce bio-identical compounds, without the waste that comes with plant-produced cannabinoids.A lab can produce a year's crop worth of cannabinoids in 48 hours.We can now produce 'rare' cannabinoids, at scale.Creo is working with consumer packaged goods providers to integrate cannabinoids into products  we use every day — like skincare products — and we can expect to see them on store shelves starting in 2022. See acast.com/privacy for privacy and opt-out information.

Biosynthetic compounds — including cannabinoids — present the 'last great domestication' says Roy Lipski, CEO of Creo. His company is at the forefront of bringing lab-produced cannabinoids to market, at scale.  Cosmetics and creams will be among the first products to take advantage of this technology and we can look for these products on store shelves in the not-too-distant future. Tune in to hear how:<ul><li>Microorganisms can produce bio-identical compounds, without the waste that comes with plant-produced cannabinoids.</li><li>A lab can produce a year's crop worth of cannabinoids in 48 hours.</li><li>We can now produce 'rare' cannabinoids, at scale.</li><li>Creo is working with consumer packaged goods providers to integrate cannabinoids into products  we use every day — like skincare products — and we can expect to see them on store shelves starting in 2022.</li></ul> See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for privacy and opt-out information.

77 | Roy Lipski, CEO, Creo

637 - Bringing Rare Cannabinoids to Market with Creo's Roy Lipski

637 - Bringing Rare Cannabinoids to Market with Creo's Roy Lipski

637 – Bringing Rare Cannabinoids to Market with Creo’s Roy Lipski